VOD release of DMT: The Spirit Molecule in Oct 2011.
07:49 min
CLEAR ALL
Recently, there has been much excitement in the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, posttraumatic stress disorder, addiction, end-of-life anxiety, and others. However, not everyone has been included.
2
Dr. Monnica Williams is a professor, clinical psychologist, and the Canada Research Chair for Mental Health Disparities at the University of Ottawa.
Monnica T. Williams, Ph.D., ABPP, is an Associate Professor in the School of Psychology at the University of Ottawa, Canada Research Chair in Mental Health Disparities, and Director of the Laboratory for Culture and Mental Health Disparities.
Psychedelic drugs: a dangerous and illegal scourge; a harmless way to “turn on, tune in, drop out” – or a valuable treatment for mental illness? Research is showing that substances like MDMA and magic mushrooms, long banished to society’s fringes, are proving effective in treating...
1
This weeks video looks at the effects of MDMA/ecstasy and ketamine as a treatment option for ptsd. The biological mechanisms involved in these drugs for ptsd as well as depression/anxiety are mentioned, as well as the therapeutic benefits and research in the area.
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
Mark Haden will explore the history and current research and possible future regulation of psychedelics. He will begin with an overview of indigenous history then explore the history in Canada and why psychedelics were criminalized.
New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression.
Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.